Skip to main content
Report this ad

See also:

Selinexor approved to treat Diffuse Large B-Cell Lymphoma

(DLBCL), an aggressive form of Non-Hodgkin lymphoma (NHL). DLBCL accounts up to 30% of newly-diagnosed cases of NHL in the US.
Getty Images/file photo
Report this ad